Pharmacodynamic monitoring of mycophenolic acid therapy: improved liquid chromatography–tandem mass spectrometry method for measuring inosin-5 …
G Weißbarth, MHJ Wiesen, C Fietz… - Therapeutic drug …, 2020 - journals.lww.com
Background: Mycophenolic acid (MPA), a powerful inhibitor of lymphocyte proliferation, is
widely used in transplantation medicine and as a glucocorticoid-sparing agent in rheumatic …
widely used in transplantation medicine and as a glucocorticoid-sparing agent in rheumatic …
CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity
G Brandhorst, S Weigand, C Eberle, D Raddatz… - Clinica chimica acta, 2013 - Elsevier
BACKGROUND: Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel
diseases (IBDs) which are characterized by dysfunctional regulation of the immune system …
diseases (IBDs) which are characterized by dysfunctional regulation of the immune system …
[PDF][PDF] Neue Biomarker zur Überwachung der zellulären Immunität chronisch-entzündlicher Darmerkrankungen
S Weigand - 2013 - d-nb.info
Evolutionsbedingt entstand in der Phylogenese der Lebewesen bereits früh eine
Immunabwehr, um zwischen körpereigenen und potentiell gefährlichen, körperfremden …
Immunabwehr, um zwischen körpereigenen und potentiell gefährlichen, körperfremden …